Lewy Body Dementia Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 - 2028

  • Published : Mar-2019
  • Tables : 42
  • Figures : 172
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT1154MR
  • Format : ppt
lewy body dementia treatment market snapshot

Key Insights- Lewy Body Dementia Treatment Market

  • Global sales of lewy body dementia treatment were valued at over US$ 3,500 Mn in 2018, in line with wide-spread prevalence of lewy body dementia and subsequent need for effective treatment.
  • Cholinesterase inhibitors, valued at over US$ 2,100 Mn in 2018, will continue to remain the most lucrative category, followed by antipsychotic drugs. The minimal side effects associated with these two drug types are among the key reasons fuelling demand for these products.
  • North America will remain the largest market for lewy body dementia treatment in 2019 and beyond, owing to appropriate dementia drug regulations and superior healthcare infrastructure in the region.
  • East Asia is anticipated to emerge as the fastest-growing market for lewy body dementia treatment, as China and India spearhead demand with an ever-growing geriatric population.

Note: For actionable insights into the for lewy body dementia treatment market, request a sample.

Key Growth Drivers - Lewy Body Dementia Treatment Market 

lewy body dementia treatment market dollar opportunity
  • Government initiatives aimed at creating awareness about lewy body dementia treatment are likely to uphold growth of the market. For instance, the US has signed into a law the BOLD Infrastructure for Alzheimer’s Act, an initiative aimed at forming a public health model against Alzheimer’s disease and other dementias. The law would sanction approx. US$ 100 Mn over a period of five years to enhance public education, reinforce numerous dementia initiatives being taken by various health and social service agencies, and collect and distribute data related to cognitive decline. Additionally, the increase in funding for lewy body dementia treatment has been reinforced by the novel R&D initiative by the National Institutes of Health (NIH).
  • Increasing prevalence of lewy body dementia and the absence of concerned drugs to manage this ailment is influencing pharma companies to invest in R&D. Currently, Alzheimer’s treatment drugs are used for managing lewy body dementia; however, it is highly likely that a range of generic drugs will proliferate the market in the near future.
  • The high cost of lewy body dementia treatment has prompted healthcare providers to bring certain aspects under the ambit of reimbursements. Favorable regulations pertaining to lewy body dementia treatment have meant that economically weaker sections of the society have access to quality care, which in turn has opened up opportunities for pharmaceutical companies.
  • The burgeoning number of performed clinical trials for lewy body dementia treatment is underpinning gains in the market by bolstering the efficiency of the existing treatment options. Ongoing treatment trials for better lewy body dementia medication have the potential to drive market growth substantially, provided these trials result in successful outcomes. 

Note: For detailed information on multiple factors boosting growth of lewy body dementia treatment market, request a sample

Key Challenges Faced by Stakeholders in Lewy Body Dementia Treatment Market 

  • The adverse effects of drugs used in lewy body dementia treatment are denting consumer and caregiver confidence, creating significant challenges for market growth. For instance, long term exposure to widely used cholinesterase inhibitors for symptomatic treatment of lewy body dementia can cause side effects, such as vomiting, diarrhea, weight loss, and insomnia. The numerous side effects associated with lewy body dementia treatment drugs have been restricting the growth of lewy body dementia treatment market.
  • Although reimbursement policies are available in certain countries, governments in various countries are yet to offer support for lewy body treatment. Considering the high cost of lewy body dementia treatment, a significant population does not receive continuous care, leading to limited drug sales. Furthermore, lewy body dementia treatment requires long-term care, with various complications triggering the cost of treatment over time. The numerous technical, regulatory and economic constraints imposed during the development process of a drug remain a significant cost driver. 

Lewy Body Dementia Treatment Market – The Competitive Landscape 

lewy body dementia treatment market competition canvas

  • Swedish research-based biopharma company, BioArctic AB, announced that AbbVie has attained the FDA approval of IND application for ABBV-0805 for the treatment of individuals with Parkinson’s disease. The alpha-synuclein-targeting ABBV-0805 is the most advanced treatment in-licensed by AbbVie from BioArctic in December 2018. The antibody has been evaluated as a disease modifying treatment for Parkinson's disease.
  • Sumitomo Dainippon Pharma Co., Ltd., a Japan-based pharmaceutical company, has signed a joint research agreement with Aikomi, Ltd. to build medical devices to relieve and prevent behavioral and psychological symptoms of dementia.
  • Takeda Pharmaceutical Company Limited has announced the completion of acquisition of Shire plc. With this acquisition, Takeda Pharmaceutical has become a global, value-based, research and development driven biopharmaceutical leader headquartered in Japan. 

Other players operating in the lewy body dementia treatment market and profiled in the report include BioArctic AB, Sumitomo Dainippon Pharma Co., Ltd., Jazz Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., Bayer AG, Mylan NV, Sanofi AG, Teva Pharmaceuticals, GlaxoSmithKline, Eisai Co., Ltd., Takeda Pharmaceutical Company Ltd., Allergan Plc., Janssen Pharmaceuticals, Inc., Bausch Health Companies Inc., and Mallinckrodt Pharmacauticals.     

Note: Fact.MR report offers captivating intelligence on the competitive dashboard of lewy body dementia treatment market. Request for a report summary

Manufacturers Prioritizing Novel Product Launches to Boost Market Sustenance  

The rise in ageing population has been gradually increasing the patient pool for lewy body dementia treatment market, with leading manufacturers working on introducing new products tailored to solely focus on lewy body dementia. Pharma companies are focusing on the development of highly innovative and competitive pipeline products. To capitalize on the changing healthcare patterns, manufacturers are diversifying their treatment offerings and business expansion via strategic tie-ups with primary care hospitals and clinics in the Asian and European countries. 

Scope of the Report 

lewy body dementia treatment market taxonomy

Lewy Body Dementia Treatment Market - Research Methodology 

The Fact.MR study report on lewy body dementia treatment market offers an exhaustive analysis and assessment on worldwide lewy body dementia treatment market, which has been compiled with the aid of a proven and tested research methodology that includes primary and secondary phases. This research methodology helped the analysts arrive at perceptive insights into the growth course of lewy body dementia treatment market during the foreseeable period. Data and insights compiled for lewy body dementia treatment market further undergo numerous stages of validation and examination before they got placed in the global lewy body dementia treatment market report. The authenticity of the market statistics compiled and evaluated for the lewy body dementia treatment market is inherited from the highly reliable research methodology of Fact.MR, which promises full reliability and high precision in terms of data and insights on lewy body dementia treatment market. 

-> Request Methodology of this Report.

1. Executive Summary
      1.1. Global Market Outlook
      1.2. Demand Side Trends
      1.3. Supply Side Trends      
      1.4. Indication Roadmap
      1.5. Analysis and Recommendations

2. Market Overview
      2.1. Market Coverage / Taxonomy
      2.2. Market Definition / Scope / Limitations

3. Key Market Trends
      3.1. Key Trends Impacting the Market
      3.2. Drug Innovation / Key Development Trends

4. Key Success Factors
      4.1. Pipeline Assessment
      4.2. Disease Treatment Pathophysiology
      4.3. Key Regulations
      4.4. Disease Epidemiology

5. Global Lewy Body Dementia Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028
      5.1. Historical Market Value (US$ Mn) Analysis, 2013-2017
      5.2. Current and Future Market Value (US$ Mn) Projections, 2018-2028
             5.2.1. Y-o-Y Growth Trend Analysis
             5.2.2. Absolute $ Opportunity Analysis

6. Market Background
      6.1. Macro-Economic Factors
             6.1.1. Global GDP Growth Outlook
             6.1.2. Global Healthcare Expenditure Outlook
      6.2. Forecast Factors - Relevance & Impact
             6.2.1. Expenditure on R&D by Pharmaceutical Companies 
             6.2.2. Cost of Drugs
             6.2.3. Merger and Acquisitions
             6.2.4. Collaborative Agreements
      6.3. Value Chain
      6.4. Market Dynamics
             6.4.1. Drivers
             6.4.2. Restraints
             6.4.3. Opportunity Analysis

7. Global Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Drug Type 
      7.1. Introduction / Key Findings
      7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2013 - 2017
      7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2018 - 2018
             7.3.1. Cholinesterase Inhibitors
             7.3.2. Antipsychotic Drugs
             7.3.3. Carbidopa-Levodopa
             7.3.4. Antidepressants
             7.3.5. Benzodiazepine
             7.3.6. Modafinil
      7.4. Market Attractiveness Analysis By Drug Type

8. Global Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Indication
      8.1. Introduction / Key Findings
      8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013 - 2017
      8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2018 - 2018
             8.3.1. Dementia with Lewy Bodies (DLB)
             8.3.2. Parkinson’s Disease (PD)
      8.4. Market Attractiveness Analysis By Indication

9. Global Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Distribution Channel
      9.1. Introduction / Key Findings
      9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2017
      9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2018 - 2018
             9.3.1. Hospital Pharmacies
             9.3.2. Retail Pharmacies 
             9.3.3. Drug Stores
             9.3.4. Online Pharmacies
      9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Region
      10.1. Introduction
      10.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2017
      10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018
             10.3.1. North America
             10.3.2. Latin America
             10.3.3. Europe
             10.3.4. Middle East and Africa (MEA)
             10.3.5. East Asia
             10.3.6. South Asia
             10.3.7. Oceania
      10.4. Market Attractiveness Analysis By Region

11. North America Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      11.1. Introduction
      11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             11.3.1. By Country
                       11.3.1.1. U.S.
                       11.3.1.2. Canada
             11.3.2. By Drug Type
             11.3.3. By Indication
             11.3.4. By Distribution Channel
      11.4.  Market Attractiveness Analysis

12. Latin America Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      12.1. Introduction
      12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             12.3.1.  By Country
                       12.3.1.1. Brazil
                       12.3.1.2. Mexico
                       12.3.1.3. Argentina
                       12.3.1.4. Rest of Latin America
             12.3.2. By Drug Type
             12.3.3. By Indication
             12.3.4. By Distribution Channel
      12.4. Market Attractiveness Analysis

13. Europe Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      13.1. Introduction
      13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             13.3.1.  By Country
                       13.3.1.1. U.K.
                       13.3.1.2. Germany
                       13.3.1.3. France
                       13.3.1.4. Italy
                       13.3.1.5. Spain
                       13.3.1.6. Russia
                       13.3.1.7. Nordic
                       13.3.1.8. Poland
                       13.3.1.9. Rest of Europe
             13.3.2. By Drug Type
             13.3.3. By Indication
             13.3.4. By Distribution Channel
      13.4. Market Attractiveness Analysis

14. South Asia Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      14.1. Introduction
      14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             14.3.1.  By Country
                       14.3.1.1. India
                       14.3.1.2. Thailand
                       14.3.1.3. Indonesia
                       14.3.1.4. Malaysia
                       14.3.1.5. Rest of South Asia
             14.3.2. By Drug Type
             14.3.3. By Indication
             14.3.4. By Distribution Channel
      14.4.  Market Attractiveness Analysis

15. East Asia Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      15.1. Introduction
      15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             15.3.1. By Country
                       15.3.1.1. China
                       15.3.1.2. Japan
                       15.3.1.3. South Korea
             15.3.2. By Drug Type
             15.3.3. By Indication
             15.3.4. By Distribution Channel
      15.4. Market Attractiveness Analysis

16. Oceania Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      16.1. Introduction
      16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             16.3.1. By Country
                       16.3.1.1. Australia
                       16.3.1.2. New Zealand
             16.3.2. By Drug Type
             16.3.3. By Indication
             16.3.4. By Distribution Channel
      16.4. Market Attractiveness Analysis

17. Middle East and Africa Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      17.1. Introduction
      17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
      17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
             17.3.1. By Country
                       17.3.1.1. GCC Countries
                       17.3.1.2. Iran
                       17.3.1.3. Israel
                       17.3.1.4. Turkey
                       17.3.1.5. Rest of Middle East and Africa
             17.3.2. By Drug Type
             17.3.3. By Indication 
             17.3.4. By Distribution Channel
      17.4. Market Attractiveness Analysis

18. Emerging Countries Lewy Body Dementia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
      18.1. Introduction
             18.1.1. Market Value Proportion Analysis, By Key Countries
             18.1.2. Global Vs. Country Growth Comparison
      18.2. China Lewy Body Dementia Treatment Market Analysis
             18.2.1. Introduction
             18.2.2. Market Value Proportion Analysis by Market Taxonomy
             18.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
                       18.2.3.1. By Drug Type
                       18.2.3.2. By Distribution Channel
                       18.2.3.3. By Indication
             18.2.4. China Lewy Body Dementia Treatment Market - Competition Landscape
             18.2.5. China - Trade Analysis
      18.3. India Lewy Body Dementia Treatment Market Analysis
             18.3.1. Introduction
             18.3.2. Market Value Proportion Analysis by Market Taxonomy
             18.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
                       18.3.3.1. By Drug Type
                       18.3.3.2. By Distribution Channel
                       18.3.3.3. By Indication
             18.3.4. India Lewy Body Dementia Treatment Market - Competition Landscape
      18.4. Brazil Lewy Body Dementia Treatment Market Analysis
             18.4.1. Introduction
             18.4.2. Market Value Proportion Analysis by Market Taxonomy
             18.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
                       18.4.3.1. By Drug Type
                       18.4.3.2. By Distribution Channel
                       18.4.3.3. By Indication
             18.4.4. Mexico Lewy Body Dementia Treatment Market - Competition Landscape

19. Competition Analysis
      19.1. Competition Dashboard
      19.2. Competition Deep Dive
             19.2.1. Axovant Sciences Ltd. 
                       19.2.1.1. Overview
                       19.2.1.2. Global Manufacturing Sites
                       19.2.1.3. Drug Sales Footprint
                       19.2.1.4. Key Financials
                       19.2.1.5. Analyst Commentary
             19.2.2. BioArctic AB
             19.2.3. Eisai Co., Ltd.
             19.2.4. Sumitomo Dainippon Pharma Co., Ltd.
             19.2.5. Jazz Pharmaceuticals, Inc.
             19.2.6. Immungenetics AG
             19.2.7. Noven Pharmaceuticals, Inc.
             19.2.8. Eli Lilly and Company
             19.2.9. Novartis AG
             19.2.10. Pfizer Inc.
             19.2.11. Bayer AG
             19.2.12. Mylan NV
             19.2.13. Sanofi AG
             19.2.14. Teva Pharmaceutical Industries Limited
             19.2.15. GlaxoSmithKline plc
             19.2.16. Takeda Pharmaceutical Company Limited
             19.2.17. Allergan plc
             19.2.18. Janssen Pharmaceuticals, Inc.
             19.2.19. Bausch Health Companies Inc.
             19.2.20. Mallinckrodt Pharmaceuticals

20. Assumptions and Acronyms Used

21.  Research Methodology

Table 01 : Lewy Body Dementia Market Pipeline Assessment – Clinical Trials
Table 02: Global Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 03: Global Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 04: Global Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 05: Global Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Region
Table 06: North America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 07: North America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 08: North America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 09: North America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 10: Latin America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 11: Latin America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 12: Latin America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 13: Latin America Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 14: Europe Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 15: Europe Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 16: Europe Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 17: Europe Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 18: South Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 19: South Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 20: South Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 21: South Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 22: East Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 23: East Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 24: East Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 25: East Asia Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 26: Oceania Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 27: Oceania Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 28: Oceania Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 29: Oceania Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 30: MEA Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Country
Table 31: MEA Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 32: MEA Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 33: MEA Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 34: China Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 35: China Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 36: China Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 37: India Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 38: India Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 39: India Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel
Table 40: Brazil Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Drug Type
Table 41: Brazil Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Indication
Table 42: Brazil Lewy Body Dementia Treatment Market size (US$ Mn) Analysis 2013–2017 and forecast 2018–2028, By Distribution Channel

Figure 01: Number of clinical trials for Lewy Body Dementia, By Phase
Figure 02: Number of clinical trials for Lewy Body Dementia, By Region
Figure 03: Global Lewy Body Dementia Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2028
Figure 04: Global Lewy Body Dementia Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028
Figure 05: Share of Elderly (65+) Population by Region, 2017
Figure 06: Comparison of Elderly Population with GDP per Capita, 2016
Figure 07: GDP (US$ Trillion) and Healthcare Expenditure % (2017)
Figure 08: Global Lewy Body Dementia Treatment Market Share Analysis (%) By Drug Type, 2018 & 2028
Figure 09: Global Lewy Body Dementia Treatment Market Y-o-Y Growth (%) By Drug Type, 2018–2028
Figure 10: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Cholinesterase Inhibitors
Figure 11: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Cholinesterase Inhibitors
Figure 12: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Antipsychotic Drugs 
Figure 13: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Antipsychotic Drugs 
Figure 14: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Carbidopa-Levodopa 
Figure 15: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Carbidopa-Levodopa 
Figure 16: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Antidepressants
Figure 17: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Antidepressants
Figure 18: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Benzodiazepine
Figure 19: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Benzodiazepine
Figure 20: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Modafinil
Figure 21: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Modafinil
Figure 22: Global Lewy Body Dementia Treatment Market Attractiveness Analysis By Drug Type, 2018–2028
Figure 23: Global Lewy Body Dementia Treatment Market Share Analysis (%) By Indication, 2018 & 2028
Figure 24: Global Lewy Body Dementia Treatment Market Y-o-Y Growth (%) By Indication, 2018–2028
Figure 25: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 26: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 27: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 28: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 29: Global Lewy Body Dementia Treatment Market Attractiveness Analysis By Indication, 2018–2028
Figure 30: Global Lewy Body Dementia Treatment Market Share Analysis (%) By Distribution Channel, 2018 & 2028
Figure 31: Global Lewy Body Dementia Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2018–2028
Figure 32: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Hospital Pharmacies 
Figure 33: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Hospital Pharmacies 
Figure 34: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Retail Pharmacies 
Figure 35: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Retail Pharmacies 
Figure 36: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Drug Stores 
Figure 37: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Drug Stores 
Figure 38: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Online Pharmacies 
Figure 39: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Online Pharmacies 
Figure 40: Global Lewy Body Dementia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 41: Global Lewy Body Dementia Treatment Market Share Analysis (%) By Region, 2018 & 2028
Figure 42: Global Lewy Body Dementia Treatment Market Y-o-Y Growth (%) By Region, 2018–2028
Figure 43: Global Lewy Body Dementia Treatment Market Value, 2013–2017, North America
Figure 44: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, North America
Figure 45: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Latin America
Figure 46: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Latin America
Figure 47: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Europe
Figure 48: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Europe
Figure 49: Global Lewy Body Dementia Treatment Market Value, 2013–2017, East Asia
Figure 50: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, East Asia
Figure 51: Global Lewy Body Dementia Treatment Market Value, 2013–2017, South Asia
Figure 52: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, South Asia
Figure 53: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Oceania
Figure 54: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Oceania
Figure 55: Global Lewy Body Dementia Treatment Market Value, 2013–2017, Middle East & Africa
Figure 56: Global Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Middle East & Africa
Figure 57: Global Lewy Body Dementia Treatment Market Attractiveness Analysis By Region, 2018–2028
Figure 58: North America Lewy Body Dementia Treatment Market Value Share, By Country
Figure 59: North America Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 60: North America Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 61: North America Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 62: North America Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 63: North America Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 64: North America Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 65: North America Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 66: North America Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 67: North America Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 68: North America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 69: North America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 70: North America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 71: North America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 72: Latin America Lewy Body Dementia Treatment Market Value Share, By Country
Figure 73: Latin America Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 74: Latin America Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 75: Latin America Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 76: Latin America Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 77: Latin America Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 78: Latin America Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 79: Latin America Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 80: Latin America Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 81: Latin America Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 82: Latin America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 83: Latin America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 84: Latin America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 85: Latin America Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 86: Europe Lewy Body Dementia Treatment Market Value Share, By Country
Figure 87: Europe Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 88: Europe Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 89: Europe Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 90: Europe Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 91: Europe Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 92: Europe Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 93: Europe Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 94: Europe Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 95: Europe Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 96: Europe Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 97: Europe Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 98: Europe Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 99: Europe Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 100: South Asia Lewy Body Dementia Treatment Market Value Share, By Country
Figure 101: South Asia Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 102: South Asia Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 103: South Asia Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 104: South Asia Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 105: South Asia Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 106: South Asia Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 107: South Asia Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 108: South Asia Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 109: South Asia Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 110: South Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 111: South Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 112: South Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 113: South Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 114: East Asia Lewy Body Dementia Treatment Market Value Share, By Country
Figure 115: East Asia Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 116: East Asia Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 117: East Asia Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 118: East Asia Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 119: East Asia Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 120: East Asia Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 121: East Asia Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 122: East Asia Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 123: East Asia Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 124: East Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 125: East Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 126: East Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 127: East Asia Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 128: Oceania Lewy Body Dementia Treatment Market Value Share, By Country
Figure 129: Oceania Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 130: Oceania Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 131: Oceania Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 132: Oceania Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 133: Oceania Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 134: Oceania Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 135: Oceania Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 136: Oceania Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 137: Oceania Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 138: Oceania Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 139: Oceania Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 140: Oceania Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 141: Oceania Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 142: MEA Lewy Body Dementia Treatment Market Value Share, By Country
Figure 143: MEA Lewy Body Dementia Treatment Market Value Share, By Indication (2017 & 2028)
Figure 144: MEA Lewy Body Dementia Treatment Market Value Share, By Drug Type (2017 & 2028)
Figure 145: MEA Lewy Body Dementia Treatment Market Value Share, By Distribution Channel (2017 & 2028)
Figure 146: MEA Lewy Body Dementia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 147: MEA Lewy Body Dementia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028
Figure 148: MEA Lewy Body Dementia Treatment Market Value, 2013–2017, Dementia with Lewy Bodies (DLB)
Figure 149: MEA Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Dementia with Lewy Bodies (DLB)
Figure 150: MEA Lewy Body Dementia Treatment Market Value, 2013–2017, Parkinson’s Disease (PD)
Figure 151: MEA Lewy Body Dementia Treatment Market Value, Forecast & Y-o-Y Growth (%), 2018–2028, Parkinson’s Disease (PD)
Figure 152: MEA Lewy Body Dementia Treatment Market Attractiveness Analysis, By Country (2018-2028)
Figure 153: MEA Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 154: MEA Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 155: MEA Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 156: Global Lewy Body Dementia Treatment Market Value Proportion Analysis, By Emerging Countries, 2018
Figure 157: Lewy Body Dementia Treatment Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2028
Figure 158: China Lewy Body Dementia Treatment Market Value Analysis (US$ Mn), 2013-2017
Figure 159: China Lewy Body Dementia Treatment Market Value Forecast (US$ Mn), 2018-2028
Figure 160: China Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 161: China Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 162: China Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 163: India Lewy Body Dementia Treatment Market Value Analysis (US$ Mn), 2013-2017
Figure 164: China Lewy Body Dementia Treatment Market Value Forecast (US$ Mn), 2018-2028
Figure 165: India Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 166: India Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 167: India Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)
Figure 168: Brazil Lewy Body Dementia Treatment Market Value Analysis (US$ Mn), 2013-2017
Figure 169: Brazil Lewy Body Dementia Treatment Market Value Forecast (US$ Mn), 2018-2028
Figure 170: Brazil Lewy Body Dementia Treatment Market Attractiveness Analysis, By Drug Type (2018-2028)
Figure 171: Brazil Lewy Body Dementia Treatment Market Attractiveness Analysis, By Indication (2018-2028)
Figure 172: Brazil Lewy Body Dementia Treatment Market Attractiveness Analysis, By Distribution Channel (2018-2028)

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development